CASE DISCUSSION
Chronic Myeloid Leukemia: Targeted Therapies and Monitoring
Presented from by Dr. Ram Ganjoo
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder driven by the BCR-ABL fusion gene, which produces an abnormal tyrosine kinase. The introduction of tyrosine kinase inhibitors (TKIs) such as imatinib, dasatinib, and nilotinib has revolutionized CML treatment, transforming it into a...
Case Summary
- Chronic Myeloid Leukemia (CML) arises from myeloid progenitor cells due to a genetic translocation between chromosomes 9 and 22, forming the Philadelphia chromosome and the BCR-ABL1 oncogene. This leads to excessive cell proliferation and reduced apoptosis. While the incidence in Western data is 1.5-2 per lack, in India it's 0.8-2.2 per lack. CML is more common in males and the median age of diagnosis in India (35-40 years) is lower than in the West (55-65 years).
Speaker Profile
Dr. Ram Ganjoo
Senior Consultant Medicine & Clinical Haematology, Sarvodaya Medicentre, DelhiDr. Ram Ganjoo is a Senior Consultant in Medicine and Clinical Haematology at Sarvodaya Medicentre, Delhi. With extensive experience in managing complex hematological and internal medicine cases, he is known for his patient-centered and evidence-based approach to care. Dr. Ganjoo has a special interest in diagnosing and treating blood disorders, including anemia, leukemia, and clotting abnormalities. His commitment to excellence and continuous learning has earned him respect among peers and trust among his patients.